Rapamune 1mg Tablet

Rapamune 1mg Tablet

Prescription requiredRx Required

Salt Composition: Sirolimus

Expiry Date: 01/2028

Special offer

Price on Request

Price on Request

Inclusive of all taxes

10 Tablet in a strip

About The Product

KIDNEY TRANSPLANT

Description

Rapamune 1mg tablet is a prescription-based medication that should be taken under a doctor's guidance. The medication is used to help prevent organ rejection in kidney transplantation. Its salt composition is Sirolimus. It acts as an immunosuppressant by inhibiting the mTOR pathway and reducing T cell activation and proliferation. It belongs to the group of mTOR inhibitors (immunosuppressive agents). Regular monitoring by the healthcare professional is necessary to ensure safe and effective treatment. The patient should follow the prescribed dose exactly and report any unusual symptoms or side effects immediately.

Uses

  • Help to prevent organ rejection in patients with kidney transplantation

Side Effects

Every medication has several side effects that may vary from person to person and should be monitored by a healthcare professional. Common ones include:

  • Fatigue or weakness
  • Nausea and vomiting

  • Rash
  • Infrequent, absent, or heavy periods
  • Rapid heart rate
  • High blood sugar
  • Joint pain
  • Acne
  • Swelling of the body, including feet and hands

  • Headache
  • Fever, pain
  • High blood pressure and cholesterol levels
  • Constipation, diarrhea, stomach pain

How To Use

  • Rapamune 1mg tablet should be taken with a whole glass of water with or without food at the same time every day.
  • Do not self-administer as it can cause side effects.
  • Always follow the recommended dosage and never adjust or skip doses without consultation with a healthcare professional, as this can increase the risk of organ rejection or other complications.

How It Works

After transplantation, the immune system sees the new organ as foreign and tries to attack it. Rapamune 1mg tablet weakens this immune response by inhibiting the activity and growth of immune cells that cause rejection.

This helps the body accept and keep the transplanted organ working well.

Safety Advice

Alcohol
Alcohol can increase the risk of side effects. It is best to avoid alcohol while using Rapamune 1mg tablet.
Pregnancy
Rapamune 1mg tablet can harm the unborn baby. Inform the doctor immediately when pregnancy occurs.
Breast Feeding
It is not for sure but sirolimus may pass into breast milk and could harm the baby in many ways. Stop breastfeeding while on this medication.
Driving
Driving is usually safe and does not cause any drowsiness while using Rapamune 1mg. If the patient feels weak, dizzy, or unwell, then avoid driving and operating machines.
Kidney
Regular kidney test and drug level monitoring are necessary as Rapamune 1mg can affect kidney function while transplanting.
Liver
Dose adjustment may be needed in people with liver disease when using Rapamune tablet. Regular liver function tests are usually required.

FAQs

Rapamune 1mg is used to prevent organ rejection after kidney transplantation by reducing the immune system's attacks on the new organ.

References

  • Basa-Dénes, O., Angi, R., Kárpáti, B., Jordán, T., Ötvös, Z., Erdősi, N., ... & Glavinas, H. (2019). Dose escalation study to assess the pharmacokinetic parameters of a nano-amorphous oral sirolimus formulation in healthy volunteers. European Journal of Drug Metabolism and Pharmacokinetics, 44(6), 777-785. https://pubmed.ncbi.nlm.nih.gov/31089971/
  • Wyeth, T. M. (2017). Pr RAPAMUNE®. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021083s059,021110s076lbl.pdf
  • Tejani, A., Alexander, S., Ettenger, R., Lerner, G., Zimmerman, J., Kohaut, E., & Briscoe, D. M. (2004). Safety and pharmacokinetics of ascending single doses of sirolimus (Rapamune®, rapamycin) in pediatric patients with stable chronic renal failure undergoing dialysis 1. Pediatric transplantation, 8(2), 151-160. https://pubmed.ncbi.nlm.nih.gov/15049795/
  • Tao, C., Wen, X., Zhang, Q., & Song, H. (2019). Solid sirolimus self-microemulsifying drug delivery system: development and evaluation of tablets with sustained release property. Iranian Journal of Pharmaceutical Research: IJPR, 18(4), 1648. https://pmc.ncbi.nlm.nih.gov/articles/PMC7059041/
  • Business, B. (2017). 7.7. 1 mTOR Inhibitors Rapamune®(Sirolimus) and AfinitorⓇ. Translating Molecules into Medicines: Cross-Functional Integration at the Drug Discovery-Development Interface, 25, 258.

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Magicine PharmacopyCopyright 2026